rbST
April 27, 2009
Elanco Commissions Consumer Study on Artificial Growth Hormones
In related news, a new study released last week suggests that the majority of consumers are not concerned enough about rbST to change their purchasing or consumption habits. The report was commissioned by Elanco, the maker of the artificial growth hormone Posilac, and conducted by Statler Nagle, a strategic marketing firm. Read the news release for more information.
BACK